Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medicare Advantage

3 Undervalued Healthcare Stocks With Upside Potential

The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and technological advancements. So, investing in undervalued healthcare stocks with upside potential, Pfizer (PFE), Cigna Group (CI), and Centene Corp (CNC), could be a wise idea. Keep reading….

StockNews.com

Medicare agents might not recommend the best plans this year as profits take priority

Curbing agents’ commissions may hurt beneficiaries.

Fortune

Dr. Oz's finanical conflicts of interest

Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Learn About Medicare Advantage Plan Updates for 2025

Medicare Advantage plans are evolving, and 2025 is shaping up to bring significant improvements and opportunities for enrollees. But what exactly is changing? What updates should you know about to make informed decisions regarding your healthcare? ...

USA Today Sports Media Group

Taxpayers spend 22% more per patient to support Medicare Advantage – the private alternative to Medicare that promised to cost less

Medicare Advantage – the commercial alternative to traditional Medicare – is drawing down federal health care funds, costing taxpayers an extra 22% per enrollee to the tune of US$83 billion a year.

The Conversation

How Dr. Oz could change Medicare under President Trump

What you might expect from Oz if he runs Medicare, Medicaid, and management of the Affordable Care Act at the 6,000-person CMS.

Fortune

A glimpse into possibly health policy under Trump, including abortion-pill and gender-transition crackdowns

Donald Trump's Agenda 47 and the Heritage Foundation's Project 2025 provide plenty of clues into what health-care changes may be coming.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Shopping for a 2025 Medigap policy? There may be some good news for you

A Biden administration proposed rule, scheduled to take effect January 1, 2025, could guarantee Medigap coverage regardless of health conditions.

Fortune

What You Will Pay for Medicare in 2025

Medicare premiums for 2025, and the cost of Medicare Part A, Medicare Part B, and Part D premiums and deductibles, have gone up. Here is how much you'll pay in 2025.

Kiplinger

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Upcoming changes to the Part D drug benefit, including a $2,000 cap on out-of-pocket medication, will benefit millions of Americans. But higher premiums may also be on the way

Kiplinger

Fact check: Would Trump slash social security and Medicare?

Kamala Harris claims Donald Trump would allow medical insurance companies to deny coverage for pre-existing conditions.

Al Jazeera

How to use Medicare star ratings wisely during Open Enrollment

The star ratings offer a shorthand look at how plans measure up for quality and member experience.

Fortune

Republicans’ healthcare proposal if Trump wins? More private Medicare

Medicare Advantage plans promise enticing benefits such as free monthly premiums for drugs benefits, but problems start when people fall ill

The Guardian - US

People with certain disabilities are eligible for Medicare under age 65. Here's who qualifies and how to apply

Medicare coverage for people under 65 with disabilities is tied to Social Security Disability Insurance (SSDI) benefits.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Why Karen Lynch lost the CEO job at CVS

A trifecta of problems, some that started before she took the top job, ended the reign of one of the most powerful women in American business.

Kiplinger

Medicare or Medicare Advantage: Which Is Right for You?

From overall costs to availability of care, here's what to know about the differences between traditional Medicare and Medicare Advantage plans.

The Conversation

Medicare vs. Medicare Advantage: sales pitches are often from biased sources, the choices can be overwhelming and impartial help is not equally available to all

The 67 million Americans eligible for Medicare make an important decision every October: Should they make changes in their Medicare health insurance plans for the next calendar year?

The Independent UK

Quality ratings hit to key Medicare plan shakes Humana stock

Shares of Humana have tumbled after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus payments the company receives

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Humana Stock Sinks on Weak Medicare Star Ratings: What to Know

Humana stock is spiraling Wednesday after the CMS provided preliminary Star Ratings data for the insurer's 2025 Medicare Advantage plans.

Fortune

How to make smart Medicare Open Enrollment choices for 2025

“It's going to be challenging,” says expert Philip Moeller, who urges people to take their time.

The Independent UK

Tips for shopping for Medicare Advantage plans

Shopping season for Medicare coverage is about to begin and with it comes the annual onslaught of TV ads and choices to consider

The Independent UK

Medicare Advantage shopping season arrives with a dose of confusion and some political implications

Thinner benefits and coverage changes await many older Americans shopping for health insurance this fall

Kiplinger

Medicare Advantage Customers Face Shrinking Pool of Insurers

Medicare Advantage plan insurers are reducing their enrollments as profit margins shrink.

Fortune

How Medicare could change under a Trump or Harris presidency

Which candidate wins in November could have a major impact on Medicare and its beneficiaries.

Fortune

Older adults 65+ should get flu shots earlier in the season. Here’s why they also need stronger vaccines

Two flu vaccines are FDA-approved exclusively for people 65 and older, who are at higher risk of severe infection.

1 … 5 6 7 8

People

Chiquita BrooksLaSure

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.